Chugai Pharm Unsp/Adr (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,858,233 | 3,565,333 | 3,256,585 | 1,710,701 | 2,436,552 |
| Marketable Securities | 3,705,730 | 3,010,544 | 1,990,187 | 2,163,223 | 1,858,375 |
| Receivables | 2,968,851 | 2,212,003 | 2,274,471 | 3,959,979 | 3,239,682 |
| Inventories | 1,854,882 | 1,584,442 | 1,941,708 | 2,249,986 | 1,900,426 |
| Other current assets | 275,384 | 227,558 | 238,674 | 207,441 | 244,280 |
| TOTAL | $11,663,080 | $10,599,880 | $9,701,625 | $10,291,330 | $9,679,315 |
| Non-Current Assets | |||||
| PPE Net | 3,059,073 | 2,858,651 | 2,910,567 | 2,890,118 | 3,083,453 |
| Investments And Advances | 0 | 0 | 0 | 14,145 | 21,776 |
| Intangibles | 365,411 | 117,929 | 141,006 | 193,586 | 199,963 |
| Other Non-Current Assets | 1,452,017 | 998,792 | 967,886 | 1,007,953 | 1,017,599 |
| TOTAL | $4,876,501 | $3,975,372 | $4,019,459 | $4,105,802 | $4,322,792 |
| Total Assets | $16,539,590 | $14,575,260 | $13,721,080 | $14,397,140 | $14,002,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 852,555 | 431,330 | 798,523 | 1,615,729 | 1,385,621 |
| Other current liabilities | 1,291,927 | 767,395 | 958,159 | 888,210 | 808,480 |
| TOTAL | $2,754,216 | $1,916,356 | $2,046,341 | $3,262,721 | $2,979,540 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 157,611 | 49,546 | 69,701 | 86,587 | 115,534 |
| TOTAL | $212,953 | $109,019 | $133,125 | $166,643 | $211,621 |
| Total Liabilities | $2,967,175 | $2,025,362 | $2,179,466 | $3,429,365 | $3,191,161 |
| Shareholders' Equity | |||||
| Common Shares | 490,453 | 483,133 | 519,734 | 563,655 | 666,138 |
| Retained earnings | 12,663,280 | 11,529,760 | 10,570,040 | 9,958,811 | 9,591,855 |
| Other shareholders' equity | -53,784 | 75,683 | -40,575 | -84,493 | -67,863 |
| TOTAL | $13,572,400 | $12,549,890 | $11,541,620 | $10,967,780 | $10,810,960 |
| Total Liabilities And Equity | $16,539,575 | $14,575,252 | $13,721,086 | $14,397,145 | $14,002,121 |